Select by year:

Efficacy and safety of silver textile in the treatment of atopic dermatitis (AD)

Juenger M, Ladwig A, Staecker S, Arnold A, Kramer A, Daeschlein G, Panzig E, Haase H, Heising S

Date: 2006


Curr Med Res Opin.

Clinical effectiveness of a silk fabric in the treatment of atopic dermatitis

Ricci G, Patrizi A, Bendandi B, Menna G, Varotti E, Masi M

Date: 2004


Br J Dermatol.

Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema

Gauger A, Mempel M, Schekatz A, Schäfer T, Ring J, Abeck D

Date: 2003



Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

Date: 1998




The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis

Williams HC, Burney PG, Hay RJ Archer CB, Shipley MJ, Hunter JJ, Bingman EA, Finlay AY, Pembroke AC, Graham-Brown RA, Atherton DA, Lewis-Jones MS, Holden CA, Harper JI, Champion RH, Poyner TF, Launer J, David TJ

Date: 1994


Br J Dermatol.


Role of bacterial flora in the pathogenesis and management of atopic dermatitis

Dhar S, Kanwar AJ, Kaur S, Sharma P, Ganguly NK

Date: 1992


Indian J Med Res.


Diagnostic features of atopic dermatitis

Hanifin JM, Rajka G

Date: 1980


Acta Derm Venereol

Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results

Institute for Health Metrics and Evaluation (IHME), 2020.

Seattle, United States.

Available at (last accessed 9 August 2022).

World Health Organisation Collaborating Centre for Drug Statistics Methodology

Available at (last accessed 12 August 2022)

World Health Organization Model List of Essential Medicines – 22nd List, 2021

Geneva: World Health Organization; 2021 (WHO/MHP/HPS/EML/2021.02).

Available at WHO model list of essential medicines - 22nd list, 2021 (last accessed 12 August 2022).